Bathala MS - Search Results

1

Quantitative structure-property relationships modeling to predict in vitro and in vivo binding of drugs to the bile sequestrant, colesevelam (Welchol).

Walker JR, Brown K, Rohatagi S, Bathala MS, Xu C, Wickremasingha PK, Salazar DE, Mager DE. Walker JR, et al. Among authors: bathala ms. J Clin Pharmacol. 2009 Oct;49(10):1185-95. doi: 10.1177/0091270009340783. J Clin Pharmacol. 2009. PMID: 19783712

2

Pharmacokinetics of amlodipine and olmesartan after administration of amlodipine besylate and olmesartan medoxomil in separate dosage forms and as a fixed-dose combination.

Rohatagi S, Lee J, Shenouda M, Haworth S, Bathala MS, Allison M, Rubets I, Heyrman R, Noveck R, Salazar DE. Rohatagi S, et al. Among authors: bathala ms. J Clin Pharmacol. 2008 Nov;48(11):1309-22. doi: 10.1177/0091270008322176. J Clin Pharmacol. 2008. PMID: 18974285

3

Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans.

Bathala MS, Masumoto H, Oguma T, He L, Lowrie C, Mendell J. Bathala MS, et al. Drug Metab Dispos. 2012 Dec;40(12):2250-5. doi: 10.1124/dmd.112.046888. Epub 2012 Aug 30. Drug Metab Dispos. 2012. PMID: 22936313

4

Metabolism and disposition of [(14)C]tivantinib after oral administration to humans, dogs and rats.

Murai T, Takakusa H, Nakai D, Kamiyama E, Taira T, Kimura T, Jimbo T, Bathala M, Pickersgill F, Zahir H, Tokui T, Savage RE, Ashwell MA, Izumi T. Murai T, et al. Xenobiotica. 2014 Nov;44(11):996-1008. doi: 10.3109/00498254.2014.926572. Epub 2014 Jun 9. Xenobiotica. 2014. PMID: 24911380

5

Elimination of radioactivity following administration of [15,16-3H]naltrexone to rats and guinea pigs.

Ludden TM, Bathala MS, Malspeis L, Drum MA, Reuning RH. Ludden TM, et al. Among authors: bathala ms. Drug Metab Dispos. 1978 May-Jun;6(3):321-8. Drug Metab Dispos. 1978. PMID: 26554

6

Plasma naltrexone kinetics after intravenous bolus administration in dogs and monkeys.

Reuning RH, Batra VK, Ludden TM, Jao MY, Morrison BE, McCarthy DA, Harrigan SE, Ashcraft SB, Sams RA, Bathala MS, Staubus AE, Malspeis L. Reuning RH, et al. Among authors: bathala ms. J Pharm Sci. 1979 Apr;68(4):411-6. doi: 10.1002/jps.2600680405. J Pharm Sci. 1979. PMID: 108382

7

Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.

Malspeis L, Bathala MS, Ludden TM, Bhat HB, Frank SG, Sokoloski TD, Morrison BE, Reuning RH. Malspeis L, et al. Among authors: bathala ms. Res Commun Chem Pathol Pharmacol. 1975 Sep;12(1):43-65. Res Commun Chem Pathol Pharmacol. 1975. PMID: 810832

8

Metabolic reduction of naltrexone II. In vitro studies using liver from guinea pig, monkey and rat.

Malspeis L, Ludden TM, Bathala MS, Morrison BE, Feller DR, Reuning RH. Malspeis L, et al. Among authors: bathala ms. Res Commun Chem Pathol Pharmacol. 1976 Jul;14(3):393-406. Res Commun Chem Pathol Pharmacol. 1976. PMID: 822483

9

Pharmacokinetics of digoxin: relationship between response intensity and predicted compartmental drug levels in man.

Kramer WG, Kolibash AJ, Lewis RP, Bathala MS, Visconti JA, Reuning RH. Kramer WG, et al. Among authors: bathala ms. J Pharmacokinet Biopharm. 1979 Feb;7(1):47-61. doi: 10.1007/BF01059440. J Pharmacokinet Biopharm. 1979. PMID: 458556

10

Specificity of the digoxin radioimmunoassay with respect to dihydrodigoxin.

Kramer WG, Bathala MS, Reuning RH. Kramer WG, et al. Among authors: bathala ms. Res Commun Chem Pathol Pharmacol. 1976 May;14(1):83-8. Res Commun Chem Pathol Pharmacol. 1976. PMID: 935656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters